Inovio Pharmaceuticals Inc INO

NAS: INO | ISIN: US45773H2013 9/05/2025

1,800 USD (-1,10%)

(-1,10%) 9/05/2025

Grafiek Inovio Pharmaceuticals Inc

Grafiek Inovio Pharmaceuticals Inc

1 dag1d -1,10%
1 week1w -3,23%
1 maand1m 1,69%
3 maanden3m -15,49%
6 maanden6m -65,05%
1 jaar1j -84,15%
5 jaar5j -86,05%

Inovio Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

30 april 2025 · INOVIO to Present at Upcoming Scientific and Investor Conferences · Persbericht

29 april 2025 · INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025 · Persbericht

9 april 2025 · INOVIO to Present at Upcoming Scientific Conferences · Persbericht

18 maart 2025 · INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights · Persbericht

13 maart 2025 · INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19 · Persbericht

12 maart 2025 · INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025 · Persbericht

8 augustus 2024 · INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights · Persbericht

1 augustus 2024 · INOVIO Reports Inducement Grant Under Inducement Plan · Persbericht

25 juli 2024 · Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107 · Persbericht

25 juli 2024 · INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024 · Persbericht

Profiel Inovio Pharmaceuticals Inc

Gezondheidstechnologie

Medische Specialiteiten

Productie van wapens en munitie

Website: www.inovio.com

Hoofdzetel: San Diego, California Verenigde Staten

CEO: Jong Kim

Werknemers: 309

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe